Demaria Sandra, Ng Bruce, Devitt Mary Louise, Babb James S, Kawashima Noriko, Liebes Leonard, Formenti Silvia C
Department of Pathology, New York University School of Medicine, New York, New York, USA.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):862-70. doi: 10.1016/j.ijrobp.2003.09.012.
Ionizing radiation can reduce tumor growth outside the field of radiation, known as the abscopal effect. Although it has been reported in multiple malignancies, the abscopal effect remains a rare and poorly understood event. Ionizing radiation generates inflammatory signals and, in principle, could provide both tumor-specific antigens from dying cells and maturation stimuli that are necessary for dendritic cells' activation of tumor-specific T cells. We therefore tested the hypothesis that the abscopal effect elicited by radiation is immune mediated. This was directly tested by enhancing the number of available dendritic cells using the growth factor Flt3-Ligand (Flt3-L).
Mice bearing a syngeneic mammary carcinoma, 67NR, in both flanks were treated with Flt3-L daily for 10 days after local radiation therapy (RT) to only 1 of the 2 tumors at a single dose of 2 or 6 Gy. The second nonirradiated tumor was used as indicator of the abscopal effect. Data were analyzed using repeated measures regression.
RT alone led to growth delay exclusively of the irradiated 67NR tumor, as expected. Surprisingly, growth of the nonirradiated tumor was also impaired by the combination of RT and Flt3-L. As control, Flt3-L had no effect without RT. Importantly, the abscopal effect was shown to be tumor specific, because growth of a nonirradiated A20 lymphoma in the same mice containing a treated 67NR tumor was not affected. Moreover, no growth delay of nonirradiated 67NR tumors was observed when T cell deficient (nude) mice were treated with RT plus Flt3-L.
These results demonstrate that the abscopal effect is in part immune mediated and that T cells are required to mediate distant tumor inhibition induced by radiation.
电离辐射可抑制辐射野之外肿瘤的生长,即所谓的远隔效应。尽管在多种恶性肿瘤中均有报道,但远隔效应仍然是一种罕见且了解甚少的现象。电离辐射会产生炎症信号,原则上,它既能提供来自垂死细胞的肿瘤特异性抗原,又能提供树突状细胞激活肿瘤特异性T细胞所需的成熟刺激信号。因此,我们检验了辐射引发的远隔效应是由免疫介导的这一假设。通过使用生长因子Flt3配体(Flt3-L)增加可利用的树突状细胞数量来直接验证这一假设。
两侧均携带同基因乳腺癌67NR的小鼠,在对其中一个肿瘤进行单次剂量为2或6 Gy的局部放射治疗(RT)后,每天用Flt3-L治疗10天。将第二个未受照射的肿瘤用作远隔效应的指标。使用重复测量回归分析数据。
正如预期的那样,单独的放射治疗仅导致受照射的67NR肿瘤生长延迟。令人惊讶的是,放射治疗与Flt3-L联合使用也会损害未受照射肿瘤的生长。作为对照,在没有放射治疗的情况下,Flt3-L没有效果。重要的是,远隔效应显示具有肿瘤特异性,因为在含有经治疗的67NR肿瘤的同一小鼠中,未受照射的A20淋巴瘤的生长未受影响。此外,当用放射治疗加Flt3-L处理T细胞缺陷(裸)小鼠时,未观察到未受照射的67NR肿瘤生长延迟。
这些结果表明,远隔效应部分是由免疫介导的,并且T细胞是介导辐射诱导的远处肿瘤抑制所必需的。